BUPRENORPHIN Mepha cpr subling 0.4 mg 28 pce
7680651880027
CH-65188
N07BC01
01.01.3.
Active substances:
1 / 3
google
Details
- Product number
- 6518801
- CPT
- -
- Packaging group
- 28
- Unit
- Tablette(n)
- Composition
- buprenorphinum 0.4 mg ut buprenorphini hydrochloridum 0.43 mg, magnesii stearas, natrii citras anhydricus corresp. natrium 0.144 mg, povidonum K 29-32, acidum citricum, amylum pregelificatum, lactosum monohydricum 63.6 mg, pro compresso.
Articles (1)
Buprenorphin-Mepha 0.4 mg, Sublingualtabletten
Sublingualtabletten
28
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
buprenorphinum
|
0.4 MG | Substance | Wirkstoff (Principe actif) |
|
buprenorphini hydrochloridum
|
0.43 MG | Substance | WIZUS |
|
magnesii stearas
|
- | Substance | HNIDK |
|
natrii citras anhydricus
|
- | Substance | HNIDK |
|
natrium
|
0.144 MG | Substance | HBESI |
|
povidonum K 29-32
|
- | Substance | HNIDK |
|
acidum citricum
|
- | Substance | HNIDK |
|
amylum pregelificatum
|
- | Substance | HNIDK |
|
lactosum monohydricum
|
63.6 MG | Substance | HBESI |
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 65188
- Drug name
- Buprenorphin-Mepha, Sublingualtabletten
- Galenic form
- SUBL
- ATC Code
- N07BC01
- Authorization status
- Z
- Dispensation category
- A+
- First authorization
- 12/12/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 01.01.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BUPRENORPHIN Mepha cpr subling 0.4 mg 28 pce
- Description (DE)
- BUPRENORPHIN Mepha Subling Tabl 0.4 mg 28 Stk
- Market launch
- 12/12/2014
- Narcotic (BTM)
- A